Different yields, biopotency, and in vivo pharmacokinetics are obtained for recombinant sea bass gonadoltropins depending on the production system and DNA construct, but they show specific activation of their corresponding receptors. Gonadotropins (GTHs) are glycoprotein hormones that play a major role in the regulation of gonadal functions. Recently, we succeeded in isolating the native sea bass Fsh from sea bass pituitaries, but to ensure the availability of bioactive GTHs and no crosscontamination with other related glycoproteins, recombinant sea bass GTHs were produced using two expression systemsinsect and mammalian cells-and different constructs that yielded tethered or noncovalently bound dimers. Their production levels, binding specificity to their homologous cognate receptors, and bioactivity were investigated and compared. Both expression systems were successful in the generation of bioactive recombinant GTHs, but insect Sf9 cells yielded higher amounts of recombinant proteins than mammalian Chinese Hamster Ovary (CHO) stable clones. All recombinant GTHs activated their cognate receptors without cross-ligand binding and were able to stimulate sea bass gonadal steroidogenesis in vitro, although with different biopotencies. To assess their use for in vivo applications, their half-life in sea bass plasma was evaluated. Sf9-GTHs had a lower in vivo stability compared with CHO-GTHs due to their rapid clearance from the blood circulation. Cell-dependent glycosylation could be contributing to the final in vivo stability and biopotency of these recombinant glycoproteins. In conclusion, both insect and mammalian expression systems produced bioactive sea bass recombinant gonadotropins, although with particular features useful for different proposes (e.g., antibody production or in vivo studies, respectively).
INTRODUCTION
The gonadotropins (GTHs)-follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-produced in the pituitary gland are essential in the endocrine control of vertebrate reproduction. Together with the pituitary-derived thyroid-stimulating hormone (TSH) and the placental chorionic gonadotropin (CG), which is present only in primate and equine species, they constitute an evolutionarily conserved family of glycoprotein hormones. They are glycosylated heterodimers formed by the noncovalent association of an a subunit (Cga), which is common to all members of the family within a species, with distinct b subunits (Fshb and Lhb) that confer hormone specificity [1, 2] . Each subunit is encoded by a single, separate gene [3] . The dimerization and glycosylation are prerequisites for GTHs to achieve full biological activity.
Since late 1980s, GTHs have been isolated and characterized in several fish species [4] . As in higher vertebrates, GTHs regulate gametogenesis and steroidogenesis. Nevertheless, the functional duality between Fsh and Lh has not yet been well clarified in perciform fish, mainly because of the lack of appropriate tools for their study. In salmonids, from which most of the information regarding GTHs comes, Fsh is considered to regulate early phases of gametogenesis, such as vitellogenesis and spermatogenesis, whereas Lh is considered to be responsible for the final maturation processes, such as oocyte maturation, ovulation, and spermiation [5, 6] .
Access to bioactive and pure fractions of homologous GTHs is essential for studies aiming to reveal their differential functions in each fish species. Traditionally, pure, intact fish GTHs have been obtained by purification of the native hormones from pituitary glands. This is a highly demanding process with regard to time, cost, and the substantial amount of pituitary glands required; in addition, it has not always been successful [7, 8] . The availability of recombinant GTHs is an attractive alternative to native hormones that can facilitate physiological studies and be used in the development of biotechnological applications. They can be continually produced, assuring their availability and no cross-contamination with other related glycoproteins. The isolation and characterization of cDNAs encoding GTH subunits in a wide range of fish species provide the possibility to produce species-specific recombinant GTHs, although this has only been accomplished in a handful of fish species in the last decade. Fish recombinant GTHs have been produced by means of various expression platforms, mainly eukaryotic systems that permit appropriate posttranslational modifications, such as glycosylation [7] [8] [9] [10] [11] [12] [13] . Production was accomplished by coexpression of both subunit genes (cga and fshb/lhb) or by fusion of their cDNAs, giving rise to a single protein known as single-chain GTH. All different approaches have generated bioactive 1 Supported by Spanish Ministerio de Educació n y Ciencia grants AGL2002-12470E, AGL2005-00796, and AGL2008-02937, and Aquagenomics CSD2007-00002. recombinant GTHs, but they show different strengths and weaknesses, mainly concerning high-yield production and stability.
As a second step toward elucidating the gonadotropic regulation of gametogenesis in fish, full-length cDNAs encoding the receptors for Fsh (Fshr) and Lh (Lhr) were isolated from the gonads of several fish species [14] . As in other vertebrates, they are G protein-coupled receptors. Ligand binding activates the Gs/ adenylate cyclase pathway, and the increased cAMP levels initiate a signaling cascade that leads to steroid synthesis [15, 16] . Despite their overall structural conservation, in vitro binding and functional studies revealed promiscuous ligand recognition of fish GTH receptors, in contrast to the strict ligand selectivity described in mammals. Depending on the species and origin of the GTHs (homologous/heterologous), a promiscuous activation of the Fshr or the Lhr was reported in studies using mammalian cell lines expressing recombinant fish GTH receptors [8, 10, [17] [18] [19] [20] [21] [22] . These observations may complicate the interpretation of their specific roles.
The European sea bass is a perciform fish whose reproduction period is once a year during the winter season. Females present a group-synchronous type of ovarian development, producing three to four consecutive spawns during the 1-to 2-mo spawning period [23] [24] [25] . In this fish, the roles of Fsh in the reproductive processes are not clarified. Recently, the purification of sea bass Fsh from pituitary glands [26] has allowed the study of some aspects of steroidogenesis in this species. However, the limited quantities of hormone obtained, together with the unavailability of native Lh dimer for functional comparative studies motivated the development of recombinant GTHs.
In the available reports on production of recombinant fish GTHs, a specific expression system and DNA construct have been chosen in each case. In the present study, we intended to produce and characterize recombinant Fsh and Lh for sea bass, but also to compare expression systems and expression constructs. We chose two expression systems representing distant eukaryotes: insect (invertebrate) and mammalian cells, and DNA constructs leading to the production of both separate and tethered subunits. Finally, we assessed and compared their function regarding receptor activation specificity and biopotency, gonadal steroidogenic ability, and in vivo stability, using homologous targets and receptors. This functional characterization provides new data on sea bass GTH action in GTHreceptor interactions, and sets a fundamental basis for the use of recombinant GTHs for future applications.
MATERIALS AND METHODS

Production of Recombinant Fsh and Lh in Insect Cells (Sf9)
Construction of cga, fshb, and lhb subunit transfer vectors. Complementary DNA fragments containing the entire open reading frames (ORFs) of sea bass cga (416 bp), fshb (480 bp), and lhb (487 bp; GenBank accession numbers: AF269157, AF543314, and AF543315) were obtained by PCR using specific primers (Supplemental Table S1 , Nos. 1 to 6; available online at www. biolreprod.org) and the proofreading PfuTurbo DNA polymerase (Stratagene). Restriction sites were added at the 5 0 end of the forward and reverse primers. These fragments were directionally cloned into the donor plasmid pFastBac1 between BamHI/HindIII (pFastBac1-Cga and pFastBac1-Lhb) or EcoRI/NotI (pFastBac1-Fshb) restriction sites. All of the constructs were sequenced to confirm their identity.
Generation of recombinant baculovirus. Recombinant baculovirusexpressing sea bass cga, fshb, and lhb were generated independently using the Bac-to-Bac Baculovirus Expression System (Invitrogen). Briefly, competent Escherichia coli DH10Bac was transformed with the recombinant donor plasmids pFastBac1-Cga, pFastBac1-Fshb, or pFastBac1-Lhb for transposition into the bacmid. Recombinant bacmids were then used to transfect insect cells, Spodoptera frugiperda (Sf9), with Cellfectin Reagent (Invitrogen) according to the manufacturer's protocol. Sf9 cells were grown in monolayer at 288C in Sf-900 II SFM medium (Invitrogen) containing 100 U/ml penicillin and 100 lg/ml streptomycin (Invitrogen). After 72 h, recombinant baculovirus was harvested from the medium. Viral stocks were amplified by infection of Sf9 cells at a multiplicity of infection (MOI) of 0.1 for 48 h at 288C to achieve final viral titers of 2 3 10 7 to 5 3 10 7 plaque-forming units (pfu) per milliliter as assessed by viral plaque assay.
Production of recombinant Fsh and Lh in Sf9 cells. Monolayer cultures of Sf9 cells were grown in 75-cm 2 flasks to 80%-85% confluence (approximately 12 3 10 6 cells). Optimal results for the expression of GTH subunits were obtained when Sf9 cells were infected at an MOI of 3 pfu/ml during 4-5 days. Cells and medium were then harvested by centrifugation (110 3 g, 10 min) and stored at À808C until used. The infected cells were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0; 100 mM KCl; 1% Nonidet P-40; 1 mM PMSF; and 1 lg/ml aprotinin) and their cell membrane disrupted by brief periods of sonication on ice using a cell disrupter (Vibracell; Sonics & Materials, Inc.). Supernatants containing soluble proteins were recovered after removal of cell debris by centrifugation at 35 000 3 g for 30 min at 48C.
For production of sea bass Fsh and Lh dimers, Sf9 cells were coinfected with a 1:1 ratio of baculovirus Cga:b subunit (Fshb or Lhb, respectively) at an MOI of 3 pfu/ml. Twenty-four hours after infection, fresh culture medium was added, and cells were incubated at 288C for 4 days. Finally, the medium was harvested and the presence of recombinant dimeric GTHs assessed.
Production of Recombinant Fsh and Lh in Chinese Hamster Ovary Cells
Construction of expression plasmids. A cDNA fragment containing the entire ORF of sea bass fshb and a C-terminal 6xHis tag was obtained by PCR using the specific primers 3 and 4 (Supplemental Table S1 ) and directionally subcloned into the EcoRI/NotI-digested pcDNA3 plasmid (Invitrogen) to generate pcDNA3-Fshb. The pCMVtk-Cga plasmid contains the full-length cga cDNA under the control of the CMVtk promoter, followed by an SV40 polyadenylation signal. All of the constructs were sequenced to confirm sequence identity.
Single-chain Fsh (scFsh) and Lh (scLh) were constructed by in-frame fusion of the sea bass cga and b subunit cDNAs of each hormone using the carboxy-terminal peptide (CTP; 28 amino acids) from the human chorionic gonadotropin (hCG) b subunit as a linker. Sequential overlapping PCR [27, 28] reactions were performed using primers 7 to 15 (Supplemental Table S1 ; see Fig. 1 for a diagram) and the high-fidelity PfuTurbo DNA polymerase (Stratagene). Expression plasmids containing the hCGB (kindly provided by Dr. Irving Boime, Washington University), and the cDNAs for sea bass fshb, lhb, and cga were used as templates. In the instance of cga, the sequence coding for the signal peptide was removed. The PCR-generated fusion fragments for Fsh and Lh were completely sequenced to ensure sequence identity. Each of these tethered cDNAs (scfsh and sclh) was inserted into the expression vector pcDNA3 (Invitrogen) as BamHI/EcoRI fragments, and the resulting expression plasmids were named pCMV-scFsh and pCMV-scLh, respectively.
Generation of Chinese Hamster Ovary stable clones and production of recombinant GTHs. Chinese Hamster Ovary (CHO) cells were cultured in Dulbecco modified Eagle medium (DMEM; Invitrogen) supplemented with 100 U/ml penicillin, 100 lg/ml streptomycin, and 5% fetal bovine serum (FBS), at 378C with 5% CO 2 . Cells were transfected in 24-well plates using Lipofectamine Reagent (Invitrogen) according to the manufacturer's protocol. Equal amounts of pCMVtk-Cga and pcDNA3-Fshb were cotransfected to express the Fsh dimer, and pCMV-scFsh or pCMV-scLh was transfected to express single-chain Fsh or Lh, respectively. To obtain the stable clones, 48 h after transfection cells were replated in 96-well plates and selected in medium containing 500 lg/ml G418 (Geneticin; Invitrogen). The isolated stable clones (CHO-Fsh, CHO-scFsh, and CHO-scLh) were expanded, and the cells and conditioned medium were screened for the presence of Fsh and Lh by Northern blotting, Western blotting, and receptor activation.
For each construct, one selected clone expressing the hormone was grown according to the protocol described by Schatz et al. [29] in 75-cm 2 cell culture flasks until 80%-90% confluence in selective medium. The FBS-containing medium was then replaced by Advanced DMEM (Invitrogen) serum-free medium supplemented with 100 U/ml penicillin, 100 lg/ml streptomycin, and 1% glutamine. The cells were further incubated for 9 days at 258C. Then, the culture supernatants were harvested and stored at À808C.
using Centricon Plus-20 Biomax 5 (subunits and dimers) and Ultracel PL 30 (single chains) centrifugal filter devices (Amicon; Millipore Corp.). In the different experiments, the concentration of recombinant GTHs used is expressed as a dilution factor of the culture medium (Table 1) .
SDS-PAGE and Western Blot Analysis
Recombinant proteins were electrophoresed through 15% SDS-PAGE gels under reducing conditions (5% 2-mercaptoethanol [2-ME]). The separated proteins were transferred to PVDF membranes (Immobilon P; Millipore Corp.), blocked overnight with 5% skimmed milk at 48C, incubated with the specific antisera (dilutions 1:2000 and 1:3500) for 90 min at room temperature, washed, and further incubated with 1:2000 goat anti-rabbit immunoglobulin G (IgG) horseradish peroxidase conjugate (GAR-HRP; Bio-Rad Laboratories) for 60 min at room temperature. The immunodetection was performed by chemiluminescence (Western Blotting Luminol Reagent; Santa Cruz Biotechnology Inc.). Antibodies against sea bass (sbs) Cga and Lhb subunits (1:2000) [30] , and a mummichog (Fundulus heteroclitus) Fshb (mFshb) antibody (1:3500) [31] already tested for sea bass [26] were used as antisera. In all cases, the molecular weights were estimated by SDS-PAGE.
Glycosidase Treatments
Concentrated media (3-10 ll) containing sea bass GTH dimers were denatured at 948C for 5 min in 0.1% SDS and 50 mM 2-ME. Then, media were incubated with 2.5 units of peptide-N-glycosidase F (PNGase F; Roche Diagnostics) at 378C for 16 h in 20 mM sodium phosphate with 0.5% Nonidet P-40, pH 7.5. Deglycosylated proteins were subjected to SDS-PAGE followed by Western blot analysis.
Activation of Sea Bass Fsh and Lh Receptors
The biological activity of the recombinant hormones were analyzed using Human Embryonic Kidney (HEK) 293 cell lines stably expressing the sea bass Fsh or Lh receptor (sbsFshr and sbsLhr) and the firefly luciferase gene under the control of a promoter with cAMP responsive element (CRE)-binding sites (pCRE-LUC) [20] . Receptor activation by recombinant Fsh or Lh was indirectly measured by recording changes in luciferase activity, promoted by a rise of cAMP. Cells from the HEK 293 clones were seeded in 48-well plates and incubated with serial dilutions of recombinant sea bass Fsh or Lh preparations in Advanced DMEM media (Invitrogen). After 5 h of incubation, cells were lysed in Reporter Lysis Buffer (Promega Corp.) as indicated by the manufacturer. Cell debris was separated by centrifugation for 30 sec at 15 000 3 g, and 20 ll of the supernatant was mixed with 100 ll of luciferin reagent (20 mM Tricine KOH, pH 7.8; 0.1 mM ethylenediaminetetraacetic acid; 8 mM MgCl 2 ; 33.3 mM dithiothreitol; 270 lM coenzyme A; 530 lM ATP; and 400 lM luciferin). Light emission was measured in a luminometer (Junior; EG&G Berthold) and expressed as relative light units.
HEK 293 cells expressing the sbsFshr were also used to calculate the effective ligand concentrations (native and recombinant Fsh) inducing a halfmaximal stimulation (EC 50 ).
Recombinant human FSH (rhFSH; AFP8468A; biopotency 8000 IU/mg) was obtained from the National Hormone & Peptide Program, Harbor-UCLA Medical Center. Lyophilized hCG from urine of pregnant women was purchased at a local pharmacy (hCG-lepori 2500 IU; Farma-Lepori).
In Vitro Sex Steroid Production and Follicle Maturation
In vitro tissue culture of sea bass gonads was performed following the protocol described by Molés et al. [26] . Briefly, ovaries (in early to mid vitellogenesis) and testis (in late spermatogenesis) of adult sea bass killed between October and November were thoroughly chopped on ice with a razor blade until forming a paste. The tissue preparation was washed three times with 10 vol/wt of ice-cold Sea Bass Ringer (SBR; according to Sorbera et al. [32] ) containing 0.5% bovine serum albumin (Fraction V; Sigma-Aldrich Inc.) and 100 U/ml penicillin/ streptomycin (Invitrogen Corp.). After each wash, the tissue was centrifuged at 60 3 g for 10 min at 48C, and the supernatant was discarded. In the last wash, the preparation was filtered through a 750-lm (for testis) or 150-lm (for ovary) nylon mesh. Pieces of the gonadal preparation were transferred to 24-well plates (40 mg per well) and preincubated shaking (100 rpm) in SBR (0.5 ml per well) for 30 min at 188C. Then, the medium was replaced with fresh SBR (0.5 ml per well) containing different dilutions of recombinant sea bass Fsh or Lh. Tissues were further incubated for 20 h at 188C and 100 rpm. Finally, the medium was collected, centrifuged at 500 3 g for 15 min at 48C, and the supernatant stored at À208C until steroid analysis. Each treatment was repeated four times, and the experiments were performed in triplicate.
Follicles from adult sea bass killed in January were cultured according to Sorbera et al. [32] . Only vitellogenic and postvitellogenic intact follicles with opaque cytoplasm and no indication of yolk clarification or lipid droplet coalescence were chosen for incubation. Oocytes were manually isolated from the ovarian tissue on ice, placed in SBR, and allowed to stabilize at 188C for 30 min prior to treatments. For scFsh stimulation, follicles were placed in 48-well plates (45-70 follicles per well) containing different doses of scFsh in 250 ll of SBR. After 48 h of incubation at 188C, the medium was collected and stored at À208C until estradiol (E2) analysis. Each dose was tested in triplicate, and the experiment was repeated three times. For scLh treatment, 30 postvitellogenic follicles per dose were individually incubated in 96-well plates in 100 ll of SBR for 48 h. The experiment was repeated twice. Maturation, which included both mature/preovulatory and ovulated oocytes, was confirmed by visual assessment of volume increase, lipid droplet coalescence, yolk clarification, and germinal vesicle migration and breakdown [32] .
Hormone Analysis
Estradiol was measured by a conventional enzyme immunoassay (EIA), which was validated for sea bass in our laboratory. The protocol was similar to that previously developed for testosterone determination [33] . Briefly, culture medium was extracted with methanol, which was further evaporated. The dry CHARACTERIZATION OF RECOMBINANT SEA BASS GTH extract was reconstituted in assay buffer (EIA buffer; Cayman Chemical). Each component, E2-acetylcholinesterase tracer, anti-E2 rabbit antiserum, and E2 standards (Sigma-Aldrich Inc.), or samples were added to 96-well microtiter plates coated with mouse anti-rabbit IgG monoclonal antibodies (Clone RG-16; Sigma-Aldrich Inc.) and incubated overnight at 378C. Then, plates were rinsed, and color development was performed by addition of Ellman reagent and incubation for 2 h at 208C in the dark. Optical density was read at 405 nm using a microplate reader (Bio-Rad microplate reader model 3550). The sensitivity of the assay was 0.156 ng/ml (Bi/B0 ¼ 90%) with a slope of 0.956. The interassay coefficient of variation (n ¼ 12) was 9.38%. 11-Ketotestosterone (11-KT) was determined by an EIA developed for the Siberian sturgeon [34] and modified for use in sea bass [35] . The assay sensitivity was 0.0012 ng/ml (Bi/B0 ¼ 90%).
Levels of recombinant sea bass Lh in culture medium or plasma samples were measured by a homologous competitive ELISA according to Mateos et al. [30] . The sensitivity of the assay was 0.65 ng/ml (Bi/B0 ¼ 80%).
The amount of recombinant sea bass Fsh produced by Sf9 and CHO cells was determined by an immunodot blot assay with the mFshb antisera already described. Briefly, the proteins present in the culture media were denatured (5% 2-ME, 4 min at 958C) and immobilized in a PVDF membrane using a Bio-Dot microfiltration apparatus (Bio-Rad Laboratories). The membrane was processed as in the Western blot assay (anti-mFshb, 1:3500; GAR-HRP, 1:2000). The immunodetection was performed by chemiluminescence (Luminol Reagent) using the image system Versadoc (Bio-Rad Laboratories). The intensity of the dots was quantified with the image analysis software Quantity One v 4.4 (BioRad Laboratories). Known quantities of purified native sea bass Fsh [26] were used as standard curve.
Levels of bioactive sea bass Fsh in plasma samples were estimated by receptor activation as described above using the sbsFshr/pCRE-LUC HEK 293 stable clone [26] and 96-well plates. Plasma samples were diluted 1:25 and measured in triplicate. After 6 h of incubation, luciferase activity was quantified directly on the plates using the Steady-Glo Luciferase Assay System (Promega Corp.) and the ULTRA Evolution (Tecan) detection platform. Intraassay and interassay coefficients of variation were 6.9% and 9.5%, respectively. The sensitivity of the bioassay was 0.104 ng/ml.
By using both determination methods, the in vitro biological:immunological ratio (B:I) could be calculated (i.e., Fsh concentration from the in vitro bioassay relative to that yielded by the immunodot blot).
In Vivo Half-Life Evaluation
Juvenile sea bass (51-94 g body mass) were used for pharmacokinetic analysis of recombinant sea bass GTHs (7-10 fish per group). A single dose of Sf9-Fsh (200 ng per fish), Sf9-Lh (500 ng per fish), scLh (52 ng per fish), or scFsh (200 ng per fish) diluted in PBS was administered by intramuscular injection. Noninjected animals or animals injected with Sf9-Fshb, Sf9-Lhb, or wild-type CHO conditioned concentrated medium served as controls. Blood samples (0.2 ml) were collected at different times (0, 0.5, 1, 3, 6, 12, 24, 48, and 72 h) after injection. Plasma was obtained by centrifugation (3000 3 g for 30 min at 48C) and stored at À208C until hormone measurements. Clearance rate was calculated as the relationship clearance rate ¼ dose/area under the concentration-time curve. The area under the concentration-time curve was calculated using NCSS software.
Animals used for in vivo studies or as a source of gonadal tissue were treated in accordance with the Spanish legislation concerning the protection of animals used for experimentation or other scientific purposes.
Statistical Analysis
Data are presented as mean 6 SEM. The significance of the differences between group means of hormone levels or receptor activation (luciferase activity) was determined by one-way ANOVA followed by the Holm-Sidak method using SigmaStat 3.5 (Systat Software Inc.). Student t-test was performed to determine significant differences between treatments.
RESULTS
Production of Recombinant Sea Bass GTHs and Biochemical Properties
Dimeric or single-chain recombinant sea bass GTHs have been produced and efficiently secreted in two systems, insect (Sf9) and mammalian (CHO) cells, as detailed in Materials and Methods. Culture media from Sf9 infections and CHO selected clones were concentrated by ultrafiltration (Table 1) and analyzed for recombinant proteins. To identify and characterize the biochemical properties of the secreted hormones, a Western blot analysis was performed. After SDS-PAGE and immunoblotting of the medium containing the sea bass Sf9-Fsh or Sf9-Lh, two proteins of different molecular mass could be visualized. In the case of recombinant Sf9-Fsh, the anti-mFshb and anti-sea bass Cga reacted with proteins of approximately 12 kDa and 15.6 kDa, respectively. Both recombinant subunits were slightly smaller than the native forms purified from sea bass pituitary (Fig. 2, A and B) . For recombinant Sf9-Lh, the anti-sea bass Lhb and anti-sea bass Cga reacted with proteins of approximately 22 kDa and 15.6 kDa, respectively (Fig. 2, E  and F) . As expected, because of the larger number of amino acids, the recombinant Sf9-Lhb showed a larger size than the Sf9-Fshb. When the b subunits were individually expressed in Sf9 cells, only Lhb was secreted and detected in the culture media (Fig. 2E) , whereas Fshb remained in the infected cells, because a strong band was detected in the cell lysates but not in the culture medium ( Fig. 2A) .
Concerning the production of the Fsh dimer in CHO cells, anti-mFshb and anti-sea bass Cga reacted with two proteins of a similar size (approximately 27 kDa and approximately 24 kDa, respectively; Fig. 2, I and J). Both subunits were bigger than the Sf9-Fsh and native sea bass Fsh subunits. The Western blot analysis of culture medium from CHO cells producing single-chain Fsh or Lh revealed proteins reacting with the antimFshb (Fig. 2K ) and anti-sea bass Lhb (Fig. 2L ) with sizes of roughly 38 and 48 kDa, respectively, which would be in the range expected for the linked subunits.
The size differences found in the recombinant subunits depending on the expression system are most likely due to the degree and type of glycosylation. A deglycosylation treatment with N-glycosidase F was performed to confirm this aspect. The enzymatic treatment, which hydrolyzes all types of Nglycan chains, resulted in a decrease in size of both subunits of the recombinant Fsh and Lh dimers (Fig. 2, C, D, and J, and G and H, respectively). The observed reduction in size clearly shows that in both expression systems, the recombinant subunits were N-glycosylated, and thus the differences in molecular mass between Sf9-Fsh and CHO-Fsh were due to a greater glycosylation degree in the CHO cells.
The levels of recombinant Sf9-Lh and Sf9-Lhb secreted to the culture media by coinfected and infected Sf9 cells were 2.8 lg/ml and 2.2 lg/ml, respectively, whereas the production of CHO-scLh was 0.03 lg/ml, as quantified by ELISA. On the other hand, the production level of recombinant sea bass Fshs was estimated by using two different methods: an immunodot blot assay using anti-mFshb antisera and an in vitro bioassay using a recombinant sea bass Fshr. This approach allowed us to assess both quantity and bioactivity for each preparation. For both methods, serial dilutions of purified native sea bass Fsh were used as standard. According to the immunodot blot, the level of Sf9-Fsh production was 24.8 lg/ml, whereas the levels of CHO-Fsh and CHO-scFsh were 0.650 lg/ml and 0.405 lg/ ml, respectively. According to the activation of sbsFshr, when compared with the bioactivities of native sea bass Fsh, the Sf9-Fsh production was 4.12 lg/ml, whereas CHO-Fsh and CHOscFsh production was 0.011 lg/ml and 0.1 lg/ml, respectively (Table 1) .
Bioactivity and Specific Receptor (Fshr and Lhr) Activation
The bioactivity and specificity of the recombinant sea bass Fsh and Lh were analyzed by determination of their capacity to stimulate intracellular cAMP production in HEK 293 cells stably expressing sea bass Fshr or Lhr. Recombinant dimers 1174 (Sf9-Fsh, CHO-Fsh, and Sf9-Lh) and single-chain GTHs (CHO-scFsh and CHO-scLh) activated their corresponding receptors in a dose-dependent manner. Additionally, the b subunits obtained from infections with baculovirus Fshb or Lhb were unable to stimulate their cognate receptors (Fig. 3, A  and B) , demonstrating that only the dimers are bioactive. Dilutions of culture medium from the different expression systems (Sf9 and CHO cells) were used to stimulate the respective receptors. The minimal concentration of culture medium able to induce cAMP production significantly was 1:1000 for Sf9-Fsh and Sf9-Lh (Fig. 3, A and B) , 1:10 for CHO-Fsh and CHO-scLh (Fig. 3, C and D) , and 1:100 for CHO-scFsh (Fig. 3C) . In all cases, the maximal induction obtained was 22-to 30-fold the basal value. To evaluate ligand receptor specificity for the sea bass GTHs, all of the recombinant hormones were used to activate both sea bass GTH receptors, sbsFshr and sbsLhr. None of the GTHs showed cross-receptor binding at any of the concentrations tested because they were only able to stimulate their cognate receptors (Fig. 3, A-D) .
To expand our knowledge of ligand recognition by the sea bass GTH receptors, heterologous human GTHs (hFSH and hCG) were tested and compared with the homologous hormones. Interestingly, hFSH was able to stimulate the sbsLhr in a dosedependent manner (Fig. 3F) but not the sbsFshr, although a slight stimulation was observed when high doses (8-40 IU/ml) were used (Fig. 3E) . On the other hand, hCG activated the sbsLhr (Fig.  3F) but not the sbsFshr (Fig. 3E) .
To compare the biopotency of Fsh dimer proteins produced by each expression system (Sf9 and CHO cells) with that of the native sea bass Fsh, which is the only available GTH purified from sea bass pituitary glands, we calculated the EC 50 to induce cAMP-dependent luciferase expression of each recombinant sea bass Fsh and that obtained with different doses of native sea bass Fsh. The Sf9-Fsh was approximately 11-fold more potent (EC 50 ¼ 23 ng/ml) than the CHO-Fsh (EC 50 ¼ 260 ng/ml), and both were approximately 4-and 43-fold less potent than purified pituitary Fsh (EC 50 ¼ 6 ng/ml), respectively (Fig.  4, A and B) . However, when the CHO-scFsh was analyzed (EC 50 ¼ 14 ng/ml), the EC 50 was in the same range as that of the Sf9-Fsh and was 18-fold more potent than the CHO-Fsh. Moreover, with the measurement of both Fsh quantity (immunodot blot) and bioactivity (bioassay), the B:I could be estimated. The Sf9-Fsh and CHO-scFsh exhibited similar B:I ratios (0.16 and 0.25, respectively), whereas the B:I ratio estimated for CHO-Fsh (0.017) was about 10-fold lower (Table  2 ). This indicated a higher bioactivity for the baculovirusderived and the single-chain Fshs and supports the EC 50 results mentioned above. 
CHARACTERIZATION OF RECOMBINANT SEA BASS GTH
In Vitro Bioactivity in Gonad Culture
To determine the activity of sea bass recombinant GTHs on the target tissue, their ability to induce steroidogenesis and/or maturation in sea bass ovary and testis was tested. Preliminary in vitro experiments using several doses of sea bass recombinant GTHs (data not shown) showed a clear dosedependent effect on E2 production by ovarian tissue. In further experiments, only two doses of all recombinant dimers (Sf9-Fsh, CHO-Fsh, and Sf9-Lh) were used. The stimulatory effects of recombinant sea bass Fsh (Sf9 and CHO) and Lh (Sf9) dimers were analyzed in adult sea bass ovary during the early and mid vitellogenic stages (October to November), and all of them showed a dose-dependent effect on E2 secretion (Fig.  5A) . We observed that equivalent concentrations of Sf9-Fsh and Sf9-Lh in the range of 250 ng/ml had a similar effect in ovary E2 production. In testis of adult male sea bass, the 11-KT secretion during late spermatogenesis (October to November) was evaluated. The analysis showed that 280 ng/ml Sf9-Lh was able to stimulate 11-KT production in testis, whereas a concentration of Sf9-Fsh 10 times higher (2.480 ng/ml) was needed to obtain the same effect (Fig. 5B) . When comparing the steroid production between Sf9-Fsh and CHO-Fsh treatments, the results were consistent with those calculated for the EC 50 , and equivalent immunologically detected concentrations in the range of 2500 ng/ml had different potency. The ability of single-chain proteins to induce E2 production and maturation in vitelogenic and postvitellogenic oocytes was also analyzed. The scFsh was effective to induce E2 production in a dose-dependent manner (Fig. 6A) , and scLh was able to increase the percentage of maturing oocytes compared with CHO medium (Fig. 6B) .
In Vivo Half-Life Evaluation
Those GTH preparations showing the highest in vitro biopotency were used to evaluate their in vivo stability, allowing the comparison of recombinant hormones produced in two systems, Sf9 and CHO, which generate different glycosylation patterns. Single intramuscular injections with recombinant Fsh (Sf9-Fsh vs. CHO-scFsh) or Lh (Sf9-Lh vs. CHO-scLh) were performed, plasma was collected at designated intervals (0, 6, 12, 24, 48, and 72 h) after injection, and GTH levels were analyzed by bioassay (Fsh) or ELISA (Lh). Plasma concentration-time D, and F) by sea bass and human GTHs. HEK 293 cells expressing the GTH receptors were incubated with increasing doses of GTHs. The concentration is expressed as a dilution factor of the culture medium for sea bass recombinant GTHs (A-D) or international units per milliliter for human GTHs (E and F). Sf9-Fshb, Sf9-Lhb, or wild-type CHO conditioned concentrated medium served as control. Each point represents mean 6 SEM of three determinations. Each experiment was repeated at least three times. RLU, relative light units. Different letters indicate significant differences between doses.
1176 curves for Sf9-Lh and CHO-scLh are illustrated in Figure 7A . The analysis showed that Sf9-Lh is rapidly cleared from circulation, with a clearance rate of 3.16 ml/h. Six hours after Sf9-Lh injection, Lh levels were slightly greater (2.1-fold) than before the injection (t0), whereas Lh levels of CHO-scLhinjected animals were approximately 11-fold higher than at t0 and were maintained significantly high until 48 h (Fig. 7A) . Accordingly, the clearance rate of CHO-scLh was 40 times lower than that of Sf9-Lh (0.079 ml/h vs. 3.16 ml/h). Because very low levels of the Lh produced by the insect cells could be detected already at 6 h after injection, another injection of 1000 ng of Sf9-Lh was performed to further determine whether Sf9-Lh entered circulation or was degraded before. Blood samples were collected at 0, 0.5, 1, 3, and 6 h after injection. High levels of Lh were already bioavailable at 0.5 h, declining rapidly during the next 6 h (Fig. 7A, inset) . The calculation of the clearance rate rendered a value of 6.5 ml/h, which is in the range but further rises the one calculated before.
Regarding Fsh, the injection of either recombinant hormone, Sf9-Fsh or CHO-scFsh, led to an increase in Fsh plasma levels at 6 h after injection and decreased gradually in the next hours. CHO-scFsh showed a more prolonged life in circulation than Sf9-Fsh, as high levels of CHO-scFsh could be detected until 72 h after injection, whereas Sf9-Fsh was cleared just in 24 h (Fig. 7, B and C) . Both the mammalian-and the insect-derived Fshs were more stable than the corresponding recombinant Lhs (Fig. 7C) , and could be detected longer in circulation.
DISCUSSION
In the present study, bioactive recombinant sea bass Fsh and Lh proteins were successfully produced using two different expression systems, insect (Sf9) and mammalian (CHO) cells.
In both systems, dimer and single-chain sea bass Fsh and Lh were efficiently expressed and secreted, although the production levels obtained in the baculovirus system were considerably higher than those obtained through stable transfection of CHO cells. The levels of recombinant Sf9-Lh produced were comparable to those reported by other authors in the production of fish and mammalian GTHs using this system [36] [37] [38] . Regarding the production levels of Sf9-Fsh, CHO-Fsh, and CHO-scFsh, the combined use of an immunodot blot and an in vitro bioassay specific for sea bass Fsh allowed the evaluation of the relative bioactivity of concrete amounts of recombinant protein produced. These assays permitted us to assess protein production levels and to compare the bioactivities of the different recombinant dimer Fsh forms. The data reported here clearly showed a higher production of Sf9-Fsh than that of CHO-Fsh. When we analyzed the potency and B:I ratio, Sf9-Fsh was more bioactive than CHO-Fsh but oddly less than CHO-scFsh. These different bioactivities of the recombinant GTHs could be due to a different degree and type of glycosylation according to the expression system used [39] [40] [41] . Insect cells produce glycoproteins containing high mannose-type oligosaccharides. In contrast, mammalian cells are able to express glycoproteins with complex sialylated oligosaccharides [42] . Functionally, GTH isoforms containing more sialylated oligosaccharides are less biopotent, as has been shown for rat FSH [41] and LH [40] . This information supports our findings that Sf9-Fsh is more bioactive than CHO-Fsh. In the particular case of CHO-scFsh, the higher B:I ratio might be influenced by other aspects (e.g., being a fusion protein instead of a dimer, which avoids subunit dissociation, or the presence of the CTP that has been shown to increase extracellular stability) [43, 44] .
When b subunits were individually expressed in the baculovirus system, only Sf9-Lhb was readily detectable in the culture medium, whereas Sf9-Fshb was only found in the cell lysate. Similar situations have been reported for other recombinant GTH subunits. In a mammalian expression system, recombinant human FSHb and LHb subunits were inefficiently secreted and slowly degraded intracellularly, whereas CGa and hCGb were rapidly secreted [45] [46] [47] . In insect cells, recombinant bovine CGa was found in culture medium at 10-fold higher levels than FSHb [48] , and recombinant catfish Cga was the only of the three subunits to be successfully produced in abundance as a single subunit [49] . The reason for this behavior is not totally clear, but it is known that proteins that fail to reach their native conformation in the endoplasmic reticulum, orphan subunits, and some heterologously expressed proteins can be selectively retained and later returned to the cytosol, where they are degraded [50, 51] . Nevertheless, coexpression of both GTH subunits leads to heterodimer assembly and efficient secretion [47] [48] [49] . The functionality of the recombinant Fshs and Lhs was initially evaluated through activation of their homologous receptors (Fshr and Lhr). All sea bass recombinant GTHs activated their cognate receptors in a dose-dependent manner, showing no cross-activity on a wide range of concentrations. Besides, neither the presence of the CTP included in the single chains nor the His-tag of the Fsh dimers influenced hormone receptor binding specificity. Selective ligand-receptor interactions, which are well established in mammals, have been also described for rainbow trout by using species-specific gonadotropins [22] , and amago salmon receptors by using the ligands from a closely related species [21] . Opposite to the sea bass and rainbow trout situation, in most of the fish species analyzed, promiscuous Fshr-Lh interactions have been observed in addition to the cognate ligand-receptor pairs [38] , although the structural basis or physiological significance of this promiscuity is still unclear. When human GTHs were used to activate the sea bass receptors, sbsLhr was activated by hCG and hFSH with nearly the same potency, whereas the sbsFshr scarcely responded to hFSH. This behavior of the human GTHs on the sea bass receptors is the same as that found for the bovine GTHs [20] . The same promiscuous behavior was observed in zebrafish, amago salmon, and African catfish Lhrs [18, 19, 52] when using mammalian GTHs. The promiscuous response of the sbsLhr to mammalian FSHs (hFSH and bFSH) but not to sea bass Fsh could have its basis in the higher similarity in sequence and structure of mammalian FSHs to sea bass Lh than to sea bass Fsh, as we previously proposed [20] . On the other hand, the very weak response of sbsFshr to hFSH, together with the fact that many residues described as important for hFSH/hFSHR binding [53] are lacking in sea bass [20] , or that specificity determinants in fish b subunits are not related to charge differences as in mammals [54] , would recommend caution when using mammalian models to explain fish Fsh-receptor interactions.
In this study, all recombinant sea bass GTHs were able to induce steroid production in cultured ovarian and testis fragments. Sf9-Fsh and Sf9-Lh had a similar effect in stimulating E2 production in the ovary, whereas in testis, Sf9-Lh was more potent in stimulating 11-KT production. Other studies using recombinant fish GTHs also showed that both Fsh and Lh were able to stimulate in vitro steroid synthesis, albeit with different potencies. In red seabream, as in sea bass, Lh was also more effective than Fsh in stimulating 11-KT release [55] . In coho salmon, Lh was progressively more potent than Fsh in stimulating 11-KT production as spermatogenesis progressed through stage IV [56] . However, in zebrafish and channel catfish, recombinant Fsh was more effective in stimulating androgen release than Lh [49, 57] ; and FIG. 5. In vitro effects of recombinant GTH dimers on E2 (A) and 11-KT (B) production by sea bass ovary and testis, respectively. Tissue fragments were incubated with two doses of each recombinant GTH. In parallel, the effect of purified native Fsh in the same tissue is shown. The upper axis shows the concentrations used calculated by immunoassay (Lh ELISA and Fsh immunodot blot). Each bar represents mean 6 SEM of four determinations. Each experiment was repeated three times. Different letters indicate significant differences between doses.
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in African catfish testis, the amount of Fsh needed to obtain a significant steroid release was lower than that of Lh [58] . These different responses could be based on the developmental stage of the gonadal tissue, and therefore in the presence of the corresponding GTH receptors. In zebrafish it has been suggested that the higher levels of fshr expression could explain the higher potency of Fsh [57] . In our study, the cultured testes were in late spermatogenesis, and there is no difference in GTH receptor expression at that gonadal stage [59] . Although in teleosts both GTHs are steroidogenic, further research is needed to elucidate the differential role of each hormone in each spermatogenic stage.
Before undertaking any in vivo functional experiment, it is essential to gain knowledge on the in vivo pharmacokinetics of the recombinant GTHs. Other studies in fish had suggested that insect-produced GTHs could be rapidly cleared from circulation [13, 60] , but this has not been demonstrated or quantified. In this report, CHO-scGTHs showed a higher stability in plasma than Sf9-GTHs, which could be based in their different glycosylation because the content in terminal sialic acid residues can be a determinant for the rate at which glycoproteins are cleared from circulation [40, 41, 61] . The fusion of the two subunits and the presence of O-linked oligosaccharides in the CTP may additionally contribute to prolonging the circulating half-life of the scGTHs [43, 44, 62] .
The reason for the highest stability of Fsh compared with Lh in both systems is unknown. A relationship between the stability and the physiological role of the hormones could be hypothesized. Maintained high levels of Fsh in the bloodstream FIG. 6 . In vitro effects of recombinant single-chain Fsh and Lh on E2 production (A) and the percentage of maturation induction (B), respectively, by sea bass oocytes. Estrogen production is expressed by oocyte and percentage with respect to basal levels. Each bar represents mean 6 SEM of 3 (A) and 30 (B) determinations, and each experiment was repeated three and two times, respectively. Asterisks represent significant differences from the control (CHO medium).
FIG. 7.
In vivo half-life of recombinant GTHs. Juvenile sea bass were injected with Sf9 and CHO recombinant GTHs. A) Plasma levels of Sf9-Lh and CHO-scLh at different times after injection. The inset graphic shows plasma levels of Sf9-Lh during the 0-to 6-h postinjection period. Lh was determined by specific ELISA. B) Plasma levels of Sf9-Fsh and CHO-scFsh at different times after injection. Fsh was determined by bioassay using sbsFshr. C) Clearance rate of injected hormones is presented as percentage of plasma levels at 6 h (100%). For Sf9-Lh, plasma levels at 0.5 h were taken as 100%. Each point represents mean 6 SEM of 5-10 fish. RLU, relative light units. Different letters indicate significant differences between hours. Asterisks represent significant differences between treatments.
CHARACTERIZATION OF RECOMBINANT SEA BASS GTH would be necessary for long-term stimulation of gonadal growth, whereas short-term increases in plasma Lh would have a more specific effect in a certain phase of the reproductive cycle and should be cleared more quickly.
In conclusion, although heterologous GTHs may bind to fish GTH receptors, their physiological effects could not reproduce exactly those of homologous hormones. Thus, the production of homologous recombinant GTHs is a fundamental tool for studies on the physiology of GTHs and the development of biotechnological applications. In this study we have produced potent recombinant sea bass FSHs and LHs that mimic the natural hormones and can be used in future studies of this species. The baculovirus system is more efficient than mammalian expression systems in terms of large amounts of production, necessary to develop different detection assays (production of antibodies and standards). Because of its high potency, it is also attractive for in vitro structure-function studies of recombinant GTH analogs. However, the data obtained in vivo show a rapid clearance of the insect-produced proteins in contrast with those produced by mammalian cells. Thus, recombinant CHO-GTHs, in particular single-chain GTHs in combination with CTP, seem to be better candidates for in vivo experiments because of their increased half-life.
